1,4-naphthoquinone has been researched along with Embolism, Pulmonary in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cho, MR; Hwang, KA; Jin, YR; Kim, JH; Kim, SY; Park, YH; Ryu, CK; Son, DJ; Yun, YP | 1 |
1 other study(ies) available for 1,4-naphthoquinone and Embolism, Pulmonary
Article | Year |
---|---|
Antiplatelet and antithrombotic activities of CP201, a newly synthesized 1,4-naphthoquinone derivative.
Topics: Animals; Dose-Response Relationship, Drug; Fibrinolytic Agents; Humans; Male; Mice; Mice, Inbred ICR; Naphthoquinones; Platelet Aggregation; Platelet Aggregation Inhibitors; Pulmonary Embolism | 2004 |